GPCR - CIK 0001888886
Structure Therapeutics Inc. has filed 248 documents with the SEC between 2021 and 2026. The most frequent type is insider trade (74 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Quarterly report | 10-Q | 2026-05-07 | 2026-03-31 |
| Major company event | 8-K | 2026-05-07 | 2026-05-07 |
| Prospectus supplement | 424B5 | 2026-05-07 | - |
| Insider trade | 4 | 2026-04-23 | 2026-04-15 |
| New insider ownership | 3 | 2026-04-23 | 2026-04-15 |
| Annual report to shareholders | ARS | 2026-04-23 | 2025-12-31 |
| Proxy statement | DEF 14A | 2026-04-23 | 2026-06-17 |
| Insider trade | 4 | 2026-04-16 | 2026-04-14 |
| Major company event | 8-K | 2026-04-15 | 2026-04-15 |
| Insider trade | 4 | 2026-03-23 | 2026-03-19 |
| Insider trade | 4 | 2026-03-23 | 2026-03-19 |
| Insider trade | 4 | 2026-03-23 | 2026-03-19 |
| Insider trade | 4 | 2026-03-23 | 2026-03-19 |
| Insider trade | 4 | 2026-03-23 | 2026-03-19 |
| Insider trade | 4 | 2026-03-23 | 2026-03-19 |
| Major company event | 8-K | 2026-03-16 | 2026-03-16 |
| Insider trade | 4 | 2026-03-05 | 2026-03-03 |
| Insider trade | 4 | 2026-03-05 | 2026-03-03 |
| Insider trade | 4 | 2026-03-05 | 2026-03-03 |
| Insider trade | 4 | 2026-03-05 | 2026-03-03 |
| Insider trade | 4 | 2026-03-05 | 2026-03-03 |
| Insider trade | 4 | 2026-03-05 | 2026-03-03 |
| Employee stock plan | S-8 | 2026-02-26 | - |
| Annual report | 10-K | 2026-02-26 | 2025-12-31 |
| Major company event | 8-K | 2026-02-26 | 2026-02-26 |
| SCHEDULE 13G/A | - | 2026-02-17 | - |
| SCHEDULE 13G/A | - | 2026-02-13 | - |
| SCHEDULE 13G/A | - | 2026-02-10 | - |
| SCHEDULE 13G/A | - | 2026-02-05 | - |
| Insider trade | 4 | 2026-01-20 | 2026-01-15 |
| Major company event | 8-K | 2026-01-05 | 2025-12-30 |
| Insider trade | 4 | 2025-12-10 | 2025-12-08 |
| Major company event | 8-K | 2025-12-10 | 2025-12-09 |
| Prospectus supplement | 424B5 | 2025-12-10 | - |
| Prospectus supplement | 424B5 | 2025-12-08 | - |
| Major company event | 8-K | 2025-12-08 | 2025-12-08 |
| SCHEDULE 13G/A | - | 2025-11-14 | - |
| SCHEDULE 13G/A | - | 2025-11-14 | - |
| SCHEDULE 13G | - | 2025-11-14 | - |
| SCHEDULE 13G/A | - | 2025-11-07 | - |
| SCHEDULE 13G/A | - | 2025-11-07 | - |
| Quarterly report | 10-Q | 2025-11-06 | 2025-09-30 |
| Major company event | 8-K | 2025-11-06 | 2025-11-06 |
| Insider trade | 4 | 2025-09-22 | 2025-09-18 |
| Insider trade | 4 | 2025-09-22 | 2025-09-18 |
| Insider trade | 4 | 2025-08-20 | 2025-07-01 |
| Insider trade | 4 | 2025-08-20 | 2025-07-01 |
| SCHEDULE 13G | - | 2025-08-18 | - |
| SCHEDULE 13G/A | - | 2025-08-14 | - |
| SCHEDULE 13G/A | - | 2025-08-14 | - |